Citations to this article

Optimizing hematopoietic stem cell engraftment: a novel role for thrombopoietin
Catherine M. Verfaillie
Catherine M. Verfaillie
Published August 1, 2002
Citation Information: J Clin Invest. 2002;110(3):303-304. https://doi.org/10.1172/JCI16376.
View: Text | PDF
Commentary Article has an altmetric score of 3

Total citations by year

Year: 2016 2015 2010 2006 Total
Citations: 1 1 1 1 4
Citation information

Citations to this article (4)

Title and authors Publication Year
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
MM Green, N Chao, S Chhabra, K Corbet, C Gasparetto, A Horwitz, Z Li, JK Venkata, G Long, A Mims, D Rizzieri, S Sarantopoulos, R Stuart, AD Sung, KM Sullivan, L Costa, M Horwitz, Y Kang 		Journal of Hematology & Oncology 2016
Magnetically Targeted Stem Cell Delivery for Regenerative Medicine
J Cores, T Caranasos, K Cheng 		Journal of Functional Biomaterials 2015
Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model
Y Kang, BJ Chen, D DeOliveira, J Mito, NJ Chao, A Leri 		PloS one 2010
The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells
JM Ninos, LC Jefferies, CR Cogle, WG Kerr 		Journal of Translational Medicine 2006

Advertisement